Clinical Trial Update: Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

View source ↗

Summary

A clinical trial update examines the effect of a chemotherapy regimen combined with a tyrosinase inhibitor on reactivation of CMV and EBV in patients with acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Chemotherapy (chemotherapy)
• Tyrosinase inhibitor

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Leukemia, Lymphoblastic, Acute | Status: UNKNOWN